In this interview, Robert Hegele, MD, discusses the diagnosis and management of sHTG-related chylomicronemia syndrome, including pancreatitis risk reduction, dietary intervention, genetic testing, and...
In this interview, Robert Hegele, MD, discusses the diagnosis and management of sHTG-related chylomicronemia syndrome, including pancreatitis risk reduction, dietary intervention, genetic testing, and...
In this interview, Robert Hegele, MD, discusses the diagnosis and management of sHTG-related chylomicronemia syndrome, including pancreatitis risk reduction, dietary intervention, genetic testing, and...
In this interview, Robert Hegele, MD, discusses the diagnosis and management of sHTG-related chylomicronemia syndrome, including pancreatitis risk reduction, dietary intervention, genetic testing, and...
In this interview, Robert Hegele, MD, discusses the diagnosis and management of sHTG-related chylomicronemia syndrome, including pancreatitis risk reduction, dietary intervention, genetic testing, and...
From medication access to adherence challenges, social vulnerability can shape diabetes outcomes. In this expert Q&A, Dr. Mary Elizabeth Patti reviews evidence showing that metabolic surgery delivers...
From medication access to adherence challenges, social vulnerability can shape diabetes outcomes. In this expert Q&A, Dr. Mary Elizabeth Patti reviews evidence showing that metabolic surgery delivers...
From medication access to adherence challenges, social vulnerability can shape diabetes outcomes. In this expert Q&A, Dr. Mary Elizabeth Patti reviews evidence showing that metabolic surgery delivers...
From medication access to adherence challenges, social vulnerability can shape diabetes outcomes. In this expert Q&A, Dr. Mary Elizabeth Patti reviews evidence showing that metabolic surgery delivers...
From medication access to adherence challenges, social vulnerability can shape diabetes outcomes. In this expert Q&A, Dr. Mary Elizabeth Patti reviews evidence showing that metabolic surgery delivers...
